Rifaximin decreases virulence of Crohn’s disease-associated Escherichia coli and epithelial inflammatory responses
Rifaximin decreases virulence of Crohn’s disease-associated <i>Escherichia coli</i> and epithelial inflammatory responses, Published online: 06 February 2018; doi:10.1038/s41429-017-0022-y
Rifaximin decreases virulence of Crohn’s disease-associated Escherichia coli and epithelial inflammatory responses
from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2E4lrZB
via IFTTT
No comments:
Post a Comment